Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Tel Aviv University, Israel.
Acta Haematol. 2011;125(1-2):39-46. doi: 10.1159/000318891. Epub 2010 Dec 8.
In spite of decades of research in the field of allogeneic hematopoietic cell transplantation for the treatment of acute leukemia, controversies regarding the role of transplant still exist. These stem not only from contradictory results of different studies, but also from differences in the design and the strength of evidence of the various trials. Meta-analysis is considered the highest level of evidence and as such has the power to resolve clinical issues comparing between different treatment modalities. The aim of this review is to examine the contribution of meta-analyses to the establishment of the role of hematopoietic transplantation for acute leukemia and at the same time to highlight limitations and future directions.
尽管在异基因造血细胞移植治疗急性白血病领域已经进行了几十年的研究,但关于移植作用的争议仍然存在。这些争议不仅源于不同研究结果的矛盾,还源于不同试验的设计和证据强度的差异。荟萃分析被认为是最高级别的证据,因此具有比较不同治疗方式的能力,从而解决临床问题。本综述的目的是检验荟萃分析对确定造血移植治疗急性白血病作用的贡献,同时突出其局限性和未来方向。